Tekturna Launch Anticipated “Very Quickly” Following Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis has recruited an additional 1,000 sales reps in preparation for the launch of the antihypertensive, according to partner Speedel.